Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 40 |
| Updated: | 3/28/2019 |
| Start Date: | June 2008 |
| End Date: | June 2008 |
Retention of an Orally Administered Investigational Device in the Oropharynx of Healthy Human Male Volunteers
Single usage, open label study in 16 adult healthy males. Eligible subjects will receive a
single usage of the investigational device. Retention of the radiolabeled device will be
monitored using gamma scintigraphy.
single usage of the investigational device. Retention of the radiolabeled device will be
monitored using gamma scintigraphy.
Inclusion Criteria:
- Refrain from nasal, throat, or lung inhalants and exercise for 24 hour prior to the
test
- Are able to tolerate the procedure and
- Be generally healthy
Exclusion Criteria:
- Have history of allergy or hypersensitivity to the study ingredients
- Major diseases
- Taking medication regularly
- Radiation exposure recently
We found this trial at
1
site
Click here to add this to my saved trials
